Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Gestational Trophoblastic Tumor|Kidney Cancer|Lymphoma|Neuroblastoma|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: recombinant interleukin-11
Sponsor: Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)